These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 15016348)

  • 1. Antifibrotic therapy in scleroderma: extracellular or intracellular targeting of activated fibroblasts?
    Varga J
    Curr Rheumatol Rep; 2004 Apr; 6(2):164-70. PubMed ID: 15016348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Constitutive thrombospondin-1 overexpression contributes to autocrine transforming growth factor-beta signaling in cultured scleroderma fibroblasts.
    Mimura Y; Ihn H; Jinnin M; Asano Y; Yamane K; Tamaki K
    Am J Pathol; 2005 May; 166(5):1451-63. PubMed ID: 15855645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antagonistic effects of TNF-alpha on TGF-beta signaling through down-regulation of TGF-beta receptor type II in human dermal fibroblasts.
    Yamane K; Ihn H; Asano Y; Jinnin M; Tamaki K
    J Immunol; 2003 Oct; 171(7):3855-62. PubMed ID: 14500687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained activation of fibroblast transforming growth factor-beta/Smad signaling in a murine model of scleroderma.
    Takagawa S; Lakos G; Mori Y; Yamamoto T; Nishioka K; Varga J
    J Invest Dermatol; 2003 Jul; 121(1):41-50. PubMed ID: 12839562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine directed therapy in scleroderma: rationale, current status, and the future.
    Simms RW; Korn JH
    Curr Opin Rheumatol; 2002 Nov; 14(6):717-22. PubMed ID: 12410097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disruption of transforming growth factor beta signaling and profibrotic responses in normal skin fibroblasts by peroxisome proliferator-activated receptor gamma.
    Ghosh AK; Bhattacharyya S; Lakos G; Chen SJ; Mori Y; Varga J
    Arthritis Rheum; 2004 Apr; 50(4):1305-18. PubMed ID: 15077315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased expression of integrin alpha(v)beta3 contributes to the establishment of autocrine TGF-beta signaling in scleroderma fibroblasts.
    Asano Y; Ihn H; Yamane K; Jinnin M; Mimura Y; Tamaki K
    J Immunol; 2005 Dec; 175(11):7708-18. PubMed ID: 16301681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenesis of scleroderma. Collagen.
    Jimenez SA; Hitraya E; Varga J
    Rheum Dis Clin North Am; 1996 Nov; 22(4):647-74. PubMed ID: 8923589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulation of the soluble guanylate cyclase (sGC) inhibits fibrosis by blocking non-canonical TGFβ signalling.
    Beyer C; Zenzmaier C; Palumbo-Zerr K; Mancuso R; Distler A; Dees C; Zerr P; Huang J; Maier C; Pachowsky ML; Friebe A; Sandner P; Distler O; Schett G; Berger P; Distler JH
    Ann Rheum Dis; 2015 Jul; 74(7):1408-16. PubMed ID: 24567525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokines and human fibrosis.
    LeRoy EC; Trojanowska MI; Smith EA
    Eur Cytokine Netw; 1990; 1(4):215-9. PubMed ID: 1966552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-HT
    Chaturvedi S; Misra DP; Prasad N; Rastogi K; Singh H; Rai MK; Agarwal V
    Int J Rheum Dis; 2018 Dec; 21(12):2128-2138. PubMed ID: 30207074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of the constitutive complex formation of c-Ski/SnoN with Smads in the impaired negative feedback regulation of transforming growth factor beta signaling in scleroderma fibroblasts.
    Jinnin M; Ihn H; Mimura Y; Asano Y; Tamaki K
    Arthritis Rheum; 2007 May; 56(5):1694-705. PubMed ID: 17469184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular pathways as novel therapeutic targets in systemic sclerosis.
    Trojanowska M; Varga J
    Curr Opin Rheumatol; 2007 Nov; 19(6):568-73. PubMed ID: 17917537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted disruption of TGF-beta/Smad3 signaling modulates skin fibrosis in a mouse model of scleroderma.
    Lakos G; Takagawa S; Chen SJ; Ferreira AM; Han G; Masuda K; Wang XJ; DiPietro LA; Varga J
    Am J Pathol; 2004 Jul; 165(1):203-17. PubMed ID: 15215176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysregulation of transforming growth factor beta signaling in scleroderma: overexpression of endoglin in cutaneous scleroderma fibroblasts.
    Leask A; Abraham DJ; Finlay DR; Holmes A; Pennington D; Shi-Wen X; Chen Y; Venstrom K; Dou X; Ponticos M; Black C; Bernabeu C; Jackman JK; Findell PR; Connolly MK
    Arthritis Rheum; 2002 Jul; 46(7):1857-65. PubMed ID: 12124870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression of TGF-beta receptors by scleroderma fibroblasts: evidence for contribution of autocrine TGF-beta signaling to scleroderma phenotype.
    Kawakami T; Ihn H; Xu W; Smith E; LeRoy C; Trojanowska M
    J Invest Dermatol; 1998 Jan; 110(1):47-51. PubMed ID: 9424086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased expression of integrin alphavbeta5 induces the myofibroblastic differentiation of dermal fibroblasts.
    Asano Y; Ihn H; Yamane K; Jinnin M; Tamaki K
    Am J Pathol; 2006 Feb; 168(2):499-510. PubMed ID: 16436664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of TGF-beta signaling in the pathogenesis of fibrosis in scleroderma.
    Ihn H
    Arch Immunol Ther Exp (Warsz); 2002; 50(5):325-31. PubMed ID: 12455866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and regulation of intracellular SMAD signaling in scleroderma skin fibroblasts.
    Mori Y; Chen SJ; Varga J
    Arthritis Rheum; 2003 Jul; 48(7):1964-78. PubMed ID: 12847691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-6 and Type-I Collagen Production by Systemic Sclerosis Fibroblasts Are Differentially Regulated by Interleukin-17A in the Presence of Transforming Growth Factor-Beta 1.
    Dufour AM; Alvarez M; Russo B; Chizzolini C
    Front Immunol; 2018; 9():1865. PubMed ID: 30150989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.